E
Epi-Minder
Medical technology company with a focus on epilepsy monitoring
About Epi-Minder
Epiminder is a healthcare technology company focused on improving the lives of individuals with epilepsy through advanced monitoring solutions. The company operates in the medical device market, targeting patients diagnosed with epilepsy, particularly those who have not responded well to traditional treatments. Epiminder's core product is a sub-scalp EEG monitoring device that continuously records brain electrical activity, providing valuable data to healthcare providers. This data helps in better understanding and managing epileptic seizures, leading to more effective treatment plans. The business model revolves around selling these devices to hospitals, clinics, and directly to patients, generating revenue through device sales and potentially through data analytics services in the future. Epiminder aims to empower patients by giving them greater control over their condition and reducing the uncertainties associated with epilepsy.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Melbourne, Australia
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Bionics Institute
University of Melbourne
Cochlear
St. Vincent's Hospital Melbourne Pty
Seer Medical
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Epi-Minder on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Epi-Minder on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.